Trials / Terminated
TerminatedNCT01800097
Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent
Treatment of Post Stroke Fatigue With Modafinil, Effect on Rehabilitation, Fatigue and Bonemass Index
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Herlev Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an investigator initiated placebo controlled double blinded trial. The hypothesis is that treatment with modafinil positively will affect behavioural and cognitive rehabilitation after stroke, causing the treatment group to experience decreased fatigue, increased endurance, improved skills of sustaining attention and faster reaction times. The cognitive rehabilitation will show in increased muscle mass, decreased osteoporosis and better physical performances due to a higher level of physical activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | modafinil | Tablet, 400 mg once daily, morning (200 mg if age 65 or above) for 3 months |
| DRUG | placebo | Tablets, 400 mg once daily ( 200 mg if age 65 or above)morning for 3 months. |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2013-02-27
- Last updated
- 2015-06-24
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01800097. Inclusion in this directory is not an endorsement.